Download technical materials

About Us

Save the earth with cells.

The cells are amazing.

Mankind should make more use of cells.

There are no tools to fully utilize cells.

We make good tools.

 

Company Information

Company Name

CellFiber Co., Ltd.

Established

April 1st, 2015

Location

216 UT South Clinical Research Building, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-8485, JAPAN

Business

Research, development, production, and sale of biomaterials,
including cells, and soft materials

 

Board Member

Member1

Representative Director, CEO

Yu Yanagisawa, Ph.D.(Chemistry)

Yu Yanagisawa received his PhD in Chemical and Biomolecular Engineering, Graduate School of Engineering, The University of Tokyo. During his studies, he conducted research on functional polymer materials in Takuzo Aida’s laboratory. He joined CellFiber in February 2018, became a director in May of the same year, and assumed the position of representative director in June 2019. Immediately after joining the company, he has been serving as a principal investigator in projects sponsored by AMED, NEDO, etc., and has been leading the business of CellFiber.

Aki Adachi

Representative Director, CAO

Aki Adachi M.A.(Biology)

Aki Adachi received her master’s degree from Graduate School of Arts and Sciences, the University of Tokyo (Shoji Takeuchi Laboratory, Institute of Industrial Science). After working for a private company for several years, she was appointed as the research promoter of the JST ERATO Takeuchi Bio Integration Project. In April 2015, together with Takeuchi, Okitsu, and Onoe, she established CellFiber Co., Ltd. based on the cell fiber technology that was the result of the ERATO project, and became the representative director. Currently, she is responsible for the development of internal and external business infrastructure and serves as the representative with Yanagisawa.

Hidetoshi Hoshiya

Board Director, COO

Hidetoshi Hoshiya, PhD FRSA MRSB (Regenerative Medicine)

After receiving a Ph.D. in regenerative medicine from Tottori University (Japan), he engaged in research at Tottori University, San Raffaele Scientific Institute (Italy), University College London, and Queen Mary University of London (UK). Since 2015, as the manager for the Asian and Oceanian territory, he developed, refined, and implemented the strategy of the Cell and Gene Therapy Catapult, an organization established by the UK government for the industrialization of regenerative medicine, including gene and cell therapy. In November 2019, he became an independent consultant for Start-up, Non-profit, Large pharmaceutical companies in Europe and Asia such as France, UK, and Japan. In December 2020, he was appointed to the board of CellFiber. He has over 15 years of experience in regenerative medicine, cell and gene therapy field.

Hiroaki Onoe

Board Director

Hiroaki Onoe, Ph.D.(Mechanical Engineering)

Hiroaki Onoe received his PhD in Information Science and Engineering from the University of Tokyo, and had been an assistant professor in Shoji Takeuchi’s lab since April 2009, where he developed cell fiber technology as an assistant researcher and group leader of the ERATO Takeuchi Project. He started his career as an independent PI in the Faculty of Science and Technology at Keio University in April 2014, and has also served as a Board Director of CellFiber since April 2016. In April 2017 he was awarded the Young Scientist Prize of the Commendation for Science and Technology by the Minister of Education, Culture, Sports, Science and Technology for his research on in vitro tissue formation including cell fibers.

Yoshinobu Osaka

Auditor

Yoshinobu Osaka

After joining Mitsubishi UFJ Bank, he was in charge of large corporate sales and M&A finance. In April 2016, he was appointed as a Specially Appointed Researcher in Shoji Takeuchi’s laboratory, and was selected for the JST ACCEL Program, becoming JST ACCEL Program Manager in August 2016. He also serves as President and Representative Director of Glocalink, Inc. He received his B.A. from the Graduate School of Business Administration, Keio University.

Shoji Takeuchi

Founder

Shoji Takeuchi (Mechanical Engineering)

Professor ,The University of Tokyo
Website: http://www.hybrid.iis.u-tokyo.ac.jp/

Teru Okitsu

Founder

Teru Okitsu (Medical Science)

Specially-appointed professor, The University of Tokyo

Nicholas Gaddum

Advisor

Nicholas Gaddum

 

Board Member

Representative Director, CEO

Yu Yanagisawa, Ph.D.(Chemistry)

Yu Yanagisawa received his PhD in Chemical and Biomolecular Engineering, Graduate School of Engineering, The University of Tokyo. During his studies, he conducted research on functional polymer materials in Takuzo Aida’s laboratory. He joined CellFiber in February 2018, became a director in May of the same year, and assumed the position of representative director in June 2019. Immediately after joining the company, he has been serving as a principal investigator in projects sponsored by AMED, NEDO, etc., and has been leading the business of CellFiber.。

Representative Director, CAO

Aki Adachi M.A.(Biology)

Aki Adachi received her master’s degree from Graduate School of Arts and Sciences, the University of Tokyo (Shoji Takeuchi Laboratory, Institute of Industrial Science). After working for a private company for several years, she was appointed as the research promoter of the JST ERATO Takeuchi Bio Integration Project. In April 2015, together with Takeuchi, Okitsu, and Onoe, she established CellFiber Co., Ltd. based on the cell fiber technology that was the result of the ERATO project, and became the representative director. Currently, she is responsible for the development of internal and external business infrastructure and serves as the representative with Yanagisawa.

Board Director, COO

Hidetoshi Hoshiya, PhD FRSA MRSB (Regenerative Medicine)

After receiving a Ph.D. in regenerative medicine from Tottori University (Japan), he engaged in research at Tottori University, San Raffaele Scientific Institute (Italy), University College London, and Queen Mary University of London (UK). Since 2015, as the manager for the Asian and Oceanian territory, he developed, refined, and implemented the strategy of the Cell and Gene Therapy Catapult, an organization established by the UK government for the industrialization of regenerative medicine, including gene and cell therapy. In November 2019, he became an independent consultant for Start-up, Non-profit, Large pharmaceutical companies in Europe and Asia such as France, UK, and Japan. In December 2020, he was appointed to the board of CellFiber. He has over 15 years of experience in regenerative medicine, cell and gene therapy field.

Board Director

Hiroaki Onoe, Ph.D.(Mechanical Engineering)

Hiroaki Onoe received his PhD in Information Science and Engineering from the University of Tokyo, and had been an assistant professor in Shoji Takeuchi’s lab since April 2009, where he developed cell fiber technology as an assistant researcher and group leader of the ERATO Takeuchi Project. He started his career as an independent PI in the Faculty of Science and Technology at Keio University in April 2014, and has also served as a Board Director of CellFiber since April 2016. In April 2017 he was awarded the Young Scientist Prize of the Commendation for Science and Technology by the Minister of Education, Culture, Sports, Science and Technology for his research on in vitro tissue formation including cell fibers.

Auditor

Yoshinobu Osaka

After joining Mitsubishi UFJ Bank, he was in charge of large corporate sales and M&A finance. In April 2016, he was appointed as a Specially Appointed Researcher in Shoji Takeuchi’s laboratory, and was selected for the JST ACCEL Program, becoming JST ACCEL Program Manager in August 2016. He also serves as President and Representative Director of Glocalink, Inc. He received his B.A. from the Graduate School of Business Administration, Keio University.

Founder

Shoji Takeuchi (Mechanical Engineering)

Professor ,The University of Tokyo

Website: http://www.hybrid.iis.u-tokyo.ac.jp/

Founder

Teru Okitsu (Medical Science)

Specially-appointed professor, The University of Tokyo

Advisor

Nicholas Gaddum

Nicholas Gaddum

Detailed profile >>

Achievement

Awards / Grants

2021-07-14

We have received NEDO STS grant.

View Details
Awards / Grants

2020-02-12

We received the grant for "Creating next generation innovative project 2020" by Tokyo Metropolitan Small and Medium Enterprise Support Center.

View Details
Awards / Grants

2020-02-06

We have won the grand prize at Tokyo Business Design Award!

View Details

News

Conference

2021-08-04

[9/1] Presenting at RINK Forum 2021. (Only in Japanese)

View Details
Co-research

2021-07-29

Co-research paper with Kyoto University and HiLung Co., Ltd. was published at "Biomaterials" online.

View Details
Awards / Grants

2021-07-14

We have received NEDO STS grant.

View Details

Joint Research Partners


  • Setsuro Tech Inc.
  • Myoridge Co. Ltd.
  • Leave a Nest Co., Ltd.
  • HiLung Inc.
  • Tokushima University: Molecular endocrinology research subfield
  • Keio University: Miki Laboratory, Faculty of Science and Technology
  • Osaka University: Biochemical Engineering Area, Department of Biotechnology, Division of Biotechnology, School / Graduate School of Engineering
  • Musashino University: Laboratory of Life Analytical Chemistry, Institute of Pharmaceutical Sciences
    (In no particular order)

Media


  • Weekly Diamond October 26, 2019
  • the University of Tokyo's Official Magazine “Tansei”
  • ASCII Health Tech January 21, 2019
  • JST News March, 2018
  • Tankyu no Kaidan (TV Tokyo)
  • the SOCIAL  (Nippon Television Network)
  • Monnashi Academy 2.0  (Nippon Television Network)

Association


  • Manufacturing Technology Association of Biologics